Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001211583-07-000018
Filing Date
2007-03-05
Accepted
2007-03-05 17:29:22
Documents
2
Period of Report
2007-02-21

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT doc.html 3  
1 PRIMARY DOCUMENT doc.xml 3 12038
2 POWER OF ATTORNEY LETTER powerofattorney.txt EX-24 3119
  Complete submission text file 0001211583-07-000018.txt   16999
Mailing Address 4620 CREEKSTONE DRIVE SUITE 200 DURHAM NC 27703
Business Address 4620 CREEKSTONE DRIVE SUITE 200 DURHAM NC 27703 919-484-8484
ADHEREX TECHNOLOGIES INC (Issuer) CIK: 0001211583 (see all company filings)

EIN.: 000000000
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address INNOVATIVE DRUG DELIVERY SYSTEMS, INC. 130 WEST 42ND STREET, 12TH FLOOR NEW YORK NY 10036
Business Address (212) 554-4550
Mermelstein Fred H (Reporting) CIK: 0001311357 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-32295 | Film No.: 07672390